Title: Conclusion of an agreement for distribution of the Issuer'stechnological solutions
Legal basis: Article 17(1) MAR - inside information
Content of the Report:
The Management Board of XTPL S.A. ("Issuer", "Company", "XTPL") reportsthat on 4 January 2022 an agreement was signed between the Issuer andmerconics GmbH _amp; Co. KG based in Germany ("merconics"), providing fordistribution of the Issuer's technological solutions in selectedEuropean countries ("Agreement").
Under the agreement, merconics will be the distributor of XTPL'stechnological solutions in Europe on the German, Austrian, French andSwiss markets, among others. The purpose of the cooperation is tosupport the Issuer in expanding the range of applications for theCompany's technology and products at R_amp;D centers, scientificinstitutions and technological corporations. The partnership will alsoincrease awareness and visibility of the Issuer's solutions among globalmarket players.
Merconics is a European renowneddistributor active in the area ofadvanced manufacturing and analytical equipment for the semiconductorsector. For more than 20 years, it has been providing its clients -global OEMs (Original Equipment Manufacturers) - with the highestquality breakthrough technologies. Their portfolio includes solutionsfrom brands such as Bruker, Veeco, NovaCetrix or Optomec.
The Agreement with merconics is one of the activities as part ofimplementation of the Company's strategy of creatingthe internationalnetwork of distributors of XTPL technological solutions. Merconics isthe Company's fourth distributor and its second European partner next toSemitronics Sales Ltd.
The Issuer's Management Board has decided that the conclusion of theAgreement is inside information, as its implementation may have asignificant impact on the Issuer's future income position, promotion ofthe Company's technological solutions in the indicated markets, and theIssuer's perception by investors. For this reason, in the opinion of theManagement Board, the information about the conclusion of the Agreementmeets the criteria set out in Article 7(1) of the MAR.